Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Arias: A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin).... (0.09 sec) 

A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin) for …

- prsjournal.com
L Arias, JM Caminal, L Casas, C Masuet, MB … - British Medical Journal, 2008 - bjo.bmj.com
Aims: The aim of this study was to compare two treatment options for choroidal
neovascularisation (CNV) secondary to age-related macular degeneration (AMD):
(1) bevacizumab administered once a month for 3 months and thereafter as ...
Cited by 8 - Related articles - All 14 versions

Efficacy of intravitreal bevacizumab (Avastin) therapy for early and advanced neovascular …


I Krebs, S Lie, U Stolba, F Zeiler, S Felke, S … - Acta Ophthalmol, 2008 - interscience.wiley.com
Methods: A consecutive series of eyes with neovascular ARMD treated with monthly
intravitreal injections of bevacizumab (1.25 mg/0.05 ml) as long as there was
evidence of activity on fluorescein angiography (FA) and optical coherence ...
Cited by 6 - Related articles - All 3 versions

[CITATION] Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab for …


JF Arevalo, J Fromow-Guerra, JG Sanche… - Retina, 2008
Cited by 2 - Related articles

Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal …


S Sacu, S Michels, F Prager, G Weigert, R … - Eye, 2009 - nature.com
In this prospective, randomised, controlled clinical trial, 28 patients were
included. All patients were randomised 1 : 1 to 0.04 ml/1 mg of IVB or PDT plus
same day 0.1 ml/4 mg IVTA (PDT+IVTA). Follow-up examinations were performed ...
Cited by 2 - Related articles - All 3 versions

Intravitreal injection of 2.5 mg versus 1.25 mg bevacizumab (Avastin) for treatment of CNV …

- prsjournal.com
M MODARRES, M NASERIPOUR, KG … - Retina, 2009 - journals.lww.com
31 μ in 2.5 mg group (P 0.6). In 2.5 mg group, three cases of vitreous reaction
and one case of massive subretinal hemorrhage were observed. Conclusion:
Intravitreal injection of 2.5 mg bevacizumab has the same efficacy as 1.25 ...
Cited by 3 - Related articles - All 5 versions

Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor …

- prsjournal.com
WAIMAN CHAN, TYY LAI, KP CHAN, H LI, … - Retina, 2008 - journals.lww.com
2 months (P 0.001). For the 17 eyes with myopic CNV, the mean ... 28.9 pg/mL at
baseline to 3.8 pg/mL ... 5.3 pg/mL at 2 months (P 0.016), whereas the mean
PEDF level increased from 20.0 ng/mL 16.3 ng/mL at baseline to 126.0 ng/mL ...
Cited by 4 - Related articles - All 4 versions

Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization …


C Furino, F Boscia, N Recchimurzo, G Besozzi … - Acta Ophthalmologica, 2009 - interscience.wiley.com
Methods: Twelve eyes of 12 patients (mean age 76 ± 6 years) with mean best
corrected visual acuity (BCVA) of 20/100 and occult subfoveal CNV at fluorescein
angiography (FA), indocyanine-green (ICG) angiography and optical coherence ...
Cited by 5 - Related articles - All 4 versions

[CITATION] ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for …


DM Brown, M Michels, PK Kaiser, JS Heier, JP … - Ophthalmology, 2009 - sid.ir
18 : OPHTHALMOLOGY JANUARY 2009; 116(1):57-65. ANCHOR STUDY GROUP. RANIBIZUMAB
VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY FOR NEOVASCULAR ...
Cited by 8 - Cached

VISUAL OUTCOMES AND GROWTH FACTOR CHANGES OF TWO DOSAGES OF …


TYY LAI, DTL LIU, KP CHAN, FOJ LUK, … - RETINA, 2009 - journals.lww.com
TIMOTHY YY LAI, MD, FRCS,*† DAVID TL LIU, FRCS,*‡ KWOK-PING CHAN, BSC,*
FIONA OJ LUK, MRCS,*† CHI-PUI PANG, DPHIL,* DENNIS SC LAM, MD, FRCOPHTH*†
... Purpose: To evaluate the visual and growth factor changes of two ...
Related articles

Wirksamkeit und Sicherheit der transskleralen Anti-VEGF-Eingabe


PV Vécsei-Marlovits, S Binder, M Stur - Spektrum der Augenheilkunde, 2009 - Springer
Summary. Since the implementation of intravitreal in- jections using inhibitors
of angiogenesis (anti-VEGF), the course of neovascular AMD has improved signifi-
cantly in the last years. Nowadays a reliable stabilisa- tion of visual ...
Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google